Global Next Generation Molecular Assay Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Next Generation Molecular Assay Market Research Report 2024
Increasing adoption of next generation molecular assay are being witnessed all over the world, as next generation molecular assay offers various advantages over conventional testing such as the ability to perform multiple assays along with data reliability and increased speed.
According to MRAResearch’s new survey, global Next Generation Molecular Assay market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next Generation Molecular Assay market research.
Key companies engaged in the Next Generation Molecular Assay industry include Thermo Fisher Scientific, Invivoscribe, Myriad Genetics, BD, Danaher, Luminex, Siemens, Roche and Tecan, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Next Generation Molecular Assay were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Next Generation Molecular Assay market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Next Generation Molecular Assay market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher Scientific
Invivoscribe
Myriad Genetics
BD
Danaher
Luminex
Siemens
Roche
Tecan
Agilent
Segment by Type
Enzyme-Linked Immuno-Sorbent Assay
Gene Expression Profiling Assays
Polymerase Chain Reaction
Others
Hospital
Pharmaceutical Companies
Biotech Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next Generation Molecular Assay report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Next Generation Molecular Assay market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next Generation Molecular Assay market research.
Key companies engaged in the Next Generation Molecular Assay industry include Thermo Fisher Scientific, Invivoscribe, Myriad Genetics, BD, Danaher, Luminex, Siemens, Roche and Tecan, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Next Generation Molecular Assay were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Next Generation Molecular Assay market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Next Generation Molecular Assay market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Invivoscribe
Myriad Genetics
BD
Danaher
Luminex
Siemens
Roche
Tecan
Agilent
Segment by Type
Enzyme-Linked Immuno-Sorbent Assay
Gene Expression Profiling Assays
Polymerase Chain Reaction
Others
Segment by Application
Hospital
Pharmaceutical Companies
Biotech Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next Generation Molecular Assay report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source